Patients with severe preeclampsia experience less hypotension during spinal anesthesia for elective cesarean delivery than healthy parturients: a prospective cohort comparison

Anesth Analg. 2003 Sep;97(3):867-872. doi: 10.1213/01.ANE.0000073610.23885.F2.

Abstract

In this prospective cohort study, we compared the incidence and severity of spinal anesthesia (SA)-associated hypotension in severely preeclamptic (n = 30) versus healthy (n = 30) parturients undergoing cesarean delivery. After the administration of IV fluids, SA was performed with hyperbaric 0.5% bupivacaine, sufentanil, and morphine. Blood pressure (BP) was recorded before and at 2-min intervals for 30 min after SA. Clinically significant hypotension was defined as the need for ephedrine (systolic BP decrease to <100 mm Hg in healthy parturients or 30% decrease in mean BP in both groups). Despite receiving a smaller fluid volume (1653 +/- 331 mL versus 1895 +/- 150 mL; P = 0.005) and a larger bupivacaine dose (10.5 +/- 0.9 mg versus 10.0 +/- 0.7 mg; P = 0.019), the severely preeclamptic patients had a less frequent incidence of clinically significant hypotension (16.6% versus 53.3%; P = 0.006), which was less severe and required less ephedrine. The risk of hypotension was almost six times less in severely preeclamptic patients (odds ratio, 0.17; 95% confidence interval, 0.05-0.58; P = 0.006) than that in healthy patients.

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Adult
  • Anesthesia, Spinal / adverse effects*
  • Blood Pressure / physiology
  • Cesarean Section*
  • Cohort Studies
  • Female
  • Heart Rate / physiology
  • Humans
  • Hypotension / etiology
  • Hypotension / physiopathology*
  • Infant, Newborn
  • Magnesium Sulfate / therapeutic use
  • Pre-Eclampsia / drug therapy
  • Pre-Eclampsia / physiopathology*
  • Pregnancy
  • Prospective Studies
  • Tocolytic Agents / therapeutic use

Substances

  • Tocolytic Agents
  • Magnesium Sulfate